U.S. panel suggests limited approval for antipsychotic drug
Tuesday, April 7, 2009 - 17:28
in Health & Medicine
The U.S. Food and Drug Administration should consider approving a drug for people with schizophrenia who don't respond to other treatments, an advisory panel said Tuesday.